The Office of Health Economics wishes to recruit a well-qualified, highly motivated and energetic economist with an industrial organisation background applied to the health care sector, health care systems and/or the life sciences industry.
New research by the Office of Health Economics (OHE) concludes the proposed International Price Index effectively outsources pharmaceutical policy decisions to countries that “give the government a central role” vs. the U.S.’ greater reliance on the private market.
Chronic diseases affect individuals’ health status and its impact is reflected by the stock of health, which measures the amount of health of a population in a given period of time. In a new study published in Health Economics, Maria Errea and colleagues assess the health-related quality of life of a population using the EQ-5D-5L instrument to, first, estimate the impact of a set of 30 chronic diseases and, second, rank diseases according to their impact on the stock of health for a country.
Research by OHE and the University of Sussex into patients’ preferences for diagnostic tests aimed at reducing antimicrobial resistance has been published in Applied Health Economics & Health Policy. The research found that patients across Europe have different preferences, which may have significant implications for the design and uptake of diagnostic tests.